Rajesh Ramanathan

A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer

Helmut Oettle, Donald Richards, Rajesh Ramanathan et al. · Annals of Oncology · 2005 · 304 citations · Full text

Urology, Oncology, Surgical Oncology +8

Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282

Rajesh Ramanathan, Avital Cnaan, R. G. Hahn et al. · Annals of Oncology · 2001 · 180 citations · Full text

Oncology, Phase Ii Trial, Pancreatic Cancer +8

Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells

Giuseppe Pettinato, Sylvain Lehoux, Rajesh Ramanathan et al. · Scientific Reports · 2019 · 159 citations · Full text

A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201

P. J. Loehrer, Mark Powell, Higinia R. Cárdenes et al. · Journal of Clinical Oncology · 2008 · 154 citations

Arm B, Radiation Medicine, Pancreatic Cancer +11

Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies

Daruka Mahadevan, E. Gabriela Chiorean, Wayne B. Harris et al. · European Journal of Cancer · 2012 · 131 citations

Pro-drug Sf1126, Medicine, Pharmacology +8